Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(10 sites)

United Kingdom

Belfast City Hospital, Belfast, Northern Ireland

Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge

Queen Victoria Hospital NHS Foundation Trust, East Grinstead

Royal Liverpool Hospital, Liverpool

Moorfields Eye Hospital NHS Foundation Trust, London

Barnet Hospital, Royal Free London NHS Foundation Trust, London

King's College Hospital NHS Foundation Trust, London

Manchester Royal Eye Hospital, Manchester

Nottingham University Hospitals NHS Trust, Nottingham

Queen Alexandra Hospital, Portsmouth